Robin J Lurvink
8PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 18, 2024
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial.Vincent C J van de Vlasakker, Niels A D Guchelaar, Teun B M van den Heuvel
|Feb 11, 2023
The Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) versus Conventional Surgery on Patient-Reported Outcomes: A Comparative Cohort Study between the CAIRO6 Trial and the PROCORE Study.Checca Bakkers, Vincent C J van de Vlasakker, Koen P B Rovers
|Jan 21, 2022
The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study.Robin J Lurvink, Anouk Rijken, Checca Bakkers
|Nov 10, 2021
Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC).Robin J Lurvink, Koen P Rovers, Emma C E Wassenaar
|Jun 06, 2021
ASO Author Reflections: Treatment and Prognosis of Colorectal Peritoneal Metastases.Checca Bakkers, Robin J Lurvink, Felice N van Erning
|Jun 02, 2021
Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study.C Bakkers, R J Lurvink, A Rijken
Pageof 2
